Investing
Top Day Trader Alerts (ABK, PALM, ENMD, XOMA, MIPI, BPOP, EXPE, PCLN, HBAN, KEY, RF)
Published:
Last Updated:
These are the top day trader and active trader alerts seen in action this morning. We have details in the links over at VSInvestor.com with more details and analysis on each where applicable.
Ambac Financial Group Inc. (NYSE: ABK) is up big again on continuation of the same news from last Thursday after 50%+ gains Friday and 100%+ gains on Monday.
Palm, Inc. (NASDAQ: PALM) was down over 3% and is getting worse as some reality is coming into play over what it may fetch in a buyout.
EntreMed, Inc. (NASDAQ: ENMD) is up over 25% on cancer news this morning.
Xoma Ltd. (NASDAQ: XOMA) is surging 20% on patent awards.
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) is looking to b today’s easy winner as shares are up nearly 200% on positive cancer news.
Popular, Inc. (NASDAQ: BPOP) is up double-digits despite a securities offering and a loss.
Goldman Sachs did an analyst coverage switcheroo and shares of Expedia Inc. (NASDAQ: EXPE) are up while Priceline.com Inc. (NASDAQ: PCLN).
Huntington Bancshares Inc. (NASDAQ: HBAN), KeyCorp. (NYSE: KEY), and Regions Financial Corp. (NYSE: RF) are all lower by 2% to 3% after UBS cut their ratings down to a SELL rating.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
